These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25877213)

  • 21. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
    Mehta JL
    Can J Cardiol; 2004 Aug; 20 Suppl B():32B-36B. PubMed ID: 15309203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling.
    Ou HC; Song TY; Yeh YC; Huang CY; Yang SF; Chiu TH; Tsai KL; Chen KL; Wu YJ; Tsai CS; Chang LY; Kuo WW; Lee SD
    J Appl Physiol (1985); 2010 Jun; 108(6):1745-56. PubMed ID: 20203069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates its vascular effects.
    Fujita Y; Kakino A; Nishimichi N; Yamaguchi S; Sato Y; Machida S; Cominacini L; Delneste Y; Matsuda H; Sawamura T
    Clin Chem; 2009 Feb; 55(2):285-94. PubMed ID: 19074514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation.
    Xu S; Liu Z; Huang Y; Le K; Tang F; Huang H; Ogura S; Little PJ; Shen X; Liu P
    Transl Res; 2012 Aug; 160(2):114-24. PubMed ID: 22677363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation-dependent surface expression of LOX-1 in human platelets.
    Chen M; Kakutani M; Naruko T; Ueda M; Narumiya S; Masaki T; Sawamura T
    Biochem Biophys Res Commun; 2001 Mar; 282(1):153-8. PubMed ID: 11263985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1.
    Kakutani M; Masaki T; Sawamura T
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):360-4. PubMed ID: 10618423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
    Stancel N; Chen CC; Ke LY; Chu CS; Lu J; Sawamura T; Chen CH
    Clin Chem; 2016 Feb; 62(2):320-7. PubMed ID: 26607724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of lectin-like oxidized low-density lipoprotein-1 receptor protects against plasma-mediated vascular dysfunction associated with pre-eclampsia.
    English FA; McCarthy FP; McSweeney CL; Quon AL; Morton JS; Sawamura T; Davidge ST; Kenny LC
    Am J Hypertens; 2013 Feb; 26(2):279-86. PubMed ID: 23382414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
    Morawietz H
    Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1.
    Kumano-Kuramochi M; Shimozu Y; Wakita C; Ohnishi-Kameyama M; Shibata T; Matsunaga S; Takano-Ishikawa Y; Watanabe J; Goto M; Xie Q; Komba S; Uchida K; Machida S
    Biochem J; 2012 Feb; 442(1):171-80. PubMed ID: 22077443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1.
    Chen KC; Hsieh IC; Hsi E; Wang YS; Dai CY; Chou WW; Juo SH
    J Cell Sci; 2011 Dec; 124(Pt 23):4115-24. PubMed ID: 22135361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
    Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production.
    Mattaliano MD; Wooters J; Shih HH; Paulsen JE
    Am J Physiol Cell Physiol; 2010 May; 298(5):C1180-7. PubMed ID: 20181930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells.
    Ishiyama J; Taguchi R; Yamamoto A; Murakami K
    Atherosclerosis; 2010 Mar; 209(1):118-24. PubMed ID: 19782984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of soluble forms of lectin-like oxidized LDL receptor-1.
    Murase T; Kume N; Kataoka H; Minami M; Sawamura T; Masaki T; Kita T
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):715-20. PubMed ID: 10712396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
    Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T
    Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL.
    Zeya B; Arjuman A; Chandra NC
    Biochemistry; 2016 Aug; 55(32):4437-44. PubMed ID: 27419271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No upregulation of lectin-like oxidized low-density lipoprotein receptor-1 in serum-deprived EA.hy926 endothelial cells under oxLDL exposure, but increase in autophagy.
    Nowicki M; Zabirnyk O; Duerrschmidt N; Borlak J; Spanel-Borowski K
    Eur J Cell Biol; 2007 Oct; 86(10):605-16. PubMed ID: 17643551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium.
    Thum T; Borlak J
    J Biol Chem; 2008 Jul; 283(28):19456-64. PubMed ID: 18390905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of IL-10 on LOX-1 expression, signalling and functional activity: an atheroprotective response.
    Arjuman A; Chandra NC
    Diab Vasc Dis Res; 2013 Sep; 10(5):442-51. PubMed ID: 23811604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.